Orthopoxvirus-specific antibodies wane to undetectable levels 1 year after MVA-BN vaccination of at-risk individuals, the Netherlands, 2022 to 2023 von van Leeuwen, Leanne Pm, Shamier, Marc C, Verstrepen, Babs E, Götz, Hannelore M, Schmitz, Katharina S, Akhiyate, Najlae, Wijnans, Koen, Bogers, Susanne, van Royen, Martin E, van Gorp, Eric Cm, Koopmans, Marion Pg, de Vries, Rory D, GeurtsvanKessel, Corine H, Zaeck, Luca M

Volltext